Genetic Technology Alert. Blood Test to Diagnose Major Depression in Adults; Biomarker Identified for Triple Negative Breast Cancer; Selenium-Rich Foods could be Effective against Cancers of Skin and Blood

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This issue profiles a blood test to diagnose major depression in adults, identification of a biomarker for triple negative breast cancer, and selenium-rich foods that could be effective against cancers of skin and blood.

Table of Contents

Genetic Technology Alert. Blood Test to Diagnose Major Depression in Adults; Biomarker Identified for Triple Negative Breast Cancer; Selenium-Rich Foods could be Effective against Cancers of Skin and BloodIn This Issue1. BLOOD TEST TO DIAGNOSE MAJOR DEPRESSION IN ADULTS2. BIOMARKER IDENTIFIED FOR TRIPLE NEGATIVE BREAST CANCER3. SELENIUM-RICH FOODS COULD BE EFFECTIVE AGAINST CANCERS OF SKIN AND BLOOD4. RECENT PATENTS IN DNA MICROARRAYS




Related Research

Release Date : 08-Sep-17

Region : Global

Release Date : 08-Sep-17

Region : Global

Release Date : 01-Sep-17

Region : Global

Release Date : 25-Aug-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.